相关实验视频

Updated: Jan 7, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

白血病转分化:从病理性可塑性到基于树突细胞的免疫治疗

Joanna Dubis¹, Aleksander Czogalla², Kazimierz Kuliczkowski¹

¹Research and Development Centre, Regional Specialist Hospital at Wrocław, Kamieńskiego 73a, 51-124 Wrocław, Poland.

|December 30, 2025

概括

转差异化转化成熟的细胞没有多能性. 在白血病中,这一过程可以增强癌细胞的免疫性,为针对白血病的新型免疫疗法提供潜力.

科学领域:

细胞生物学细胞生物学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

转基因分化是将一个分化细胞直接转化为另一个分化细胞,绕过多能性.
在白血病中,转分化会影响瘤的存活率和治疗耐药性.
它还为创新的癌症疗法提供了机会,特别是通过增加癌细胞免疫性.

研究的目的:

审查白血病转分化的分子机制.
突出树突细胞在抗白血病免疫力中的作用.
讨论诱导白血病细胞转化为抗原呈现细胞的方法,用于治疗应用.

主要方法:

关于转差异化和白血病的现有文献的审查.
对参与直接重编程的分子途径的分析.
检查用于诱导细胞转换的体外和体内技术.

主要成果:

转分化可以通过促进树突细胞样表型来增强白血病细胞免疫性.
状细胞是先天性和适应性抗白血病免疫的关键组成部分.
现有特殊技术可以将白血病细胞转化为癌症抗原呈现细胞.

结论:

通过转分化利用白血病细胞可塑性为下一代免疫疗法提供了一个有希望的途径.
针对转差异化可能导致新的抗白血病治疗方法.
进一步研究诱导和控制这一过程对于治疗开发至关重要.

关键词:

树突细胞是一种树突细胞.免疫疗法免疫疗法这种白血病是白血病.白血病细胞的可塑性一部分的转差分化.通过转差异化转化.

更多相关视频

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Forced Transdifferentiation

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...